Related Experiment Video
Updated: Dec 22, 2025
Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Is Cardiac Troponin I Valuable to Detect Low-Level Myocardial Damage in Congestive Heart Failure?
1Deparment of Internal Medicine, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
Insights
Cardiac troponin I (cTnI) effectively detects low-level myocardial damage in heart failure (HF). Higher HF severity correlates with increased cTnI levels and decreased ejection fraction (EF).
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Research
Background:
- Congestive heart failure (CHF) is a growing public health concern.
- Traditional markers like creatine kinase-myocardial band (CK-MB) lack sensitivity for detecting subtle myocardial damage in heart failure (HF).
- Cardiac troponins offer superior sensitivity and specificity for identifying myocardial injury.
Purpose of the Study:
- To evaluate the utility of cardiac troponin I (cTnI) in detecting low-level myocardial damage in patients with CHF under real-world conditions.
- To assess the correlation between cTnI levels, HF severity, and left ventricular ejection fraction (EF).
Main Methods:
- A prospective study involving 50 patients with CHF symptoms (Group I) and 20 healthy controls (Group II).
- Patients were classified using Framingham criteria for HF and New York Heart Association (NYHA) functional capacity classes (II, III, IV).
- Quantitative measurements of CK-MB and cTnI were performed on admission; linear regression analyzed the relationship between EF and cTnI.
Main Results:
- Mean cTnI levels were significantly higher in CHF patients (0.084±0.07 ng/mL) compared to controls (0.018±0.012 ng/mL) (p=0.0001).
- cTnI levels increased progressively with NYHA class (Class II: 0.047±0.016; Class III: 0.080±0.048; Class IV: 0.175±0.102 ng/mL).
- A significant inverse relationship was found between EF and cTnI levels (r=-0.66, p=0.0001).
Conclusions:
- Elevated serum cTnI levels correlate with increased HF severity.
- The inverse relationship between cTnI and EF suggests cTnI is a valuable indicator of myocardial dysfunction in HF.
- cTnI serves as a sensitive biomarker for diagnosing and assessing the severity of heart failure.
Objectives:
Congestive heart failure (CHF) is a heart disease with a growing incidence and prevalence. Creatine kinase-myocardial base (CK-MB) is generally used to determine myocardial damage; however, it is insufficiently sensitive to measure the relatively low level of myocardial damage that typically occurs in heart failure (HF). The use of cardiac troponins, which are far more sensitive and specific, has become common to identify myocardial damage and permits the detection of even minute amounts of damage. The aim of this study was to ascertain whether cardiac troponin I (cTnI) can be used to detect low-level myocardial damage occurring in CHF in real-life conditions.
Methods:
Fifty patients with CHF symptoms (Group I) and 20 patients who were evaluated as normal (Group II) were included in this prospective study. The Framingham criteria were used to diagnose HF. Group I was divided into 3 subgroups according to the New York Heart Association classification of functional capacity: Class II, Group A; Class III, Group B, and Class IV, Group C. On the first day of admission, CK-MB and cTnI levels were measured and assessed quantitatively. The cTnI level was compared between these 3 subgroups and between Groups I and II. Linear regression analysis was performed to investigate the relationship between ejection fraction (EF) and cTnI.
Results:
The mean cTnI value was 0.084±0.07 ng/mL in Group I and 0.018±0.012 ng/mL in Group II (p=0.0001). The mean cTnI value was 0.047±0.016 ng/mL, 0.080±0.048 ng/mL, and 0.175± 0.102 ng/mL in Groups A, B, and C, respectively. The difference between the subgroups of Group I was statistically significant. In addition, it was observed that there was a significant difference in the EF (%) value between Groups I and II and between Groups A, B, and C. Linear regression analysis revealed an inverse relationship between EF and cTnI (r: -0.66) (p=0.0001).
Conclusion:
As the severity of HF increased, the cTnI serum level also increased. This increase was inversely related to the EF value. These results are consistent with other studies in the literature, suggesting that the cTnI level may be a useful marker in the diagnosis and evaluation of severity of HF.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome I: Introduction
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT